NCT00549133View on ClinicalTrials.gov

Irbesartan Effects on Endothelial Dysfunction in Hypertensive Type II Diabetic Patients Comparing Atenolol

PHASE4CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

October 31, 2003

Study Completion Date

April 30, 2005

Conditions
HypertensionDiabetes Mellitus Type 2
Interventions
DRUG

Irbesartan

Trial Locations (1)

Unknown

Sanofi-Aventis, Istanbul

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY